Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|January 4, 2011
Tetrahydroquinoline derivatives as opioid receptor antagonistsCunyu Zhang, Susan M Westaway, Jason D Speake, et al.
Aging Clinical and Experimental Research|January 10, 2019
Does the identification of seniors at risk (ISAR) score effectively select geriatric patients on emergency admission?W Weinrebe, Y Schiefer, K Weckmüller, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|February 19, 2002
Intermediate results of health related quality of life after vertical banded gastroplastyM E E Sabbioni, M H Dickson, S Eychmüller, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2007
Solid phase synthesis and SAR of small molecule agonists for the GPR40 receptorStephen C McKeown, David F Corbett, Aaron S Goetz, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2006
Synthesis and activity of small molecule GPR40 agonistsDulce M Garrido, David F Corbett, Kate A Dwornik, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2008
Discovery of small molecule agonists for the bombesin receptor subtype 3 (BRS-3) based on an omeprazole leadDavid L Carlton, Lissa J Collin-Smith, Alejandro J Daniels, et al.
British Journal of Pharmacology|May 17, 2006
Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small moleculesCelia P Briscoe, Andrew J Peat, Stephen C McKeown, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 30, 2011
Regulation of ingestive behaviors in the rat by GSK1521498, a novel micro-opioid receptor-selective inverse agonistDiane M Ignar, Aaron S Goetz, Kimberly Nichols Noble, et al.
Bioorganic & Medicinal Chemistry Letters|August 15, 2006
Novel benzimidazole-based MCH R1 antagonistsAndrew J Carpenter, Kamal A Al-Barazanji, Kevin K Barvian, et al.
Bioorganic & Medicinal Chemistry Letters|December 30, 2008
Thienopyrimidine-based dual EGFR/ErbB-2 inhibitorsTara R Rheault, Thomas R Caferro, Scott H Dickerson, et al.
Pageof 7